Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Boehringer, Mirati Therapeutics Enter Clinical Collaboration

contractpharmaSeptember 18, 2020

Tag: Boehringer Ingelheim , Mirati Therapeutics , MRTX849 , pan-KRAS inhibitor

PharmaSources Customer Service